Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.

[1]  O. Decaux,et al.  Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. , 2012, Autoimmunity reviews.

[2]  L. Mouthon,et al.  Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. , 2012, Seminars in arthritis and rheumatism.

[3]  L. Mouthon,et al.  Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. , 2011, Arthritis and rheumatism.

[4]  V. Limaye,et al.  Clinical heterogeneity and prognostic features of South Australian patients with anti‐synthetase autoantibodies , 2011, Internal medicine journal.

[5]  T. Mimori,et al.  Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. , 2011, Respiratory medicine.

[6]  C. Goulvestre,et al.  Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study. , 2011, Autoimmunity Reviews.

[7]  B. Wallaert,et al.  Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies , 2011, European Respiratory Journal.

[8]  C. Oddis,et al.  Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? , 2010, Chest.

[9]  B. Wallaert,et al.  Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. , 2010, Rheumatology.

[10]  G. Filippatos,et al.  Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .

[11]  L. Rönnblom,et al.  Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. , 2009, Autoimmunity reviews.

[12]  S. Sahn,et al.  Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. , 2009, Chest.

[13]  Alan Julian Izenman,et al.  Modern Multivariate Statistical Techniques: Regression, Classification, and Manifold Learning , 2008 .

[14]  T. Mimori,et al.  Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance , 2007, Current opinion in rheumatology.

[15]  M. Humbert,et al.  Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset , 2007, Thorax.

[16]  Anthony Chin Loy,et al.  Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. , 2006, Arthritis and rheumatism.

[17]  T. Mimori,et al.  Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies , 2006, Autoimmunity.

[18]  F. Trotta,et al.  In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease , 2006, Autoimmunity.

[19]  B. Schlotter-Weigel,et al.  The long-term outcome of anti-Jo-1-positive inflammatory myopathies , 2004, Journal of Neurology.

[20]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[21]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[22]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[23]  F. Arnett,et al.  Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. , 1996, Seminars in arthritis and rheumatism.

[24]  M. Dalakas,et al.  A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups , 1991, Medicine.

[25]  J. Hughes,et al.  Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. , 1990, The Quarterly journal of medicine.

[26]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[27]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[28]  H. Holman,et al.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). , 1972, The American journal of medicine.

[29]  Arnold Simanowitz,et al.  international consensus statement , 2000 .

[30]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .